Pharmaceutical

ADPH names facilities that received products from pharmacy at center of meningitis outbreak

syringe ADPH names facilities that received products from pharmacy at center of meningitis outbreakThe Alabama Department of Public Health (ADPH) is notifying facilities across the state that received products from the compounding pharmacy at the center of the deadly meningitis outbreak to remove the products from their inventory and to discuss the process for contacting patients who were treated with the recalled medications.

All products distributed by New England Compounding Center (NECC) have been recalled in the wake of an investigation into the specialty pharmacy that supplied the steroid shots that, to date, have killed 20 and infected 254 others with rare fungal meningitis. Nearly 18,000 potentially contaminated vials were shipped to 73 facilities in 23 states beginning in late May.

While no other products made by NECC have been proven to be contaminated nor have they been associated with the disease, health officials are not ruling out that other medications from the pharmacy – in particular injectable products – may be tainted as well.

Meningitis is the inflammation of the membranes surrounding the brain and spinal cord. It is most commonly caused by bacteria or viruses. Fungal meningitis is extremely rare and hard to diagnose, and it can take more than a month for symptoms to appear. Symptoms include severe headache, neck stiffness, dizziness, and nausea. If left untreated, the infection can cause permanent neurological damage and death.

While no Alabama facilities received the injections that are linked to the meningitis outbreak, several facilities across the state have received other products from NECC:

  • Andalusia Regional Hospital, Andalusia
  • Northeast Alabama Regional Medical Center, Anniston
  • Atmore Community Hospital, Atmore
  • Healthcare Authority for UAB Medical West, Bessemer
  • Alabama Pain Physicians, Birmingham
  • Baptist Medical Center-Princeton, Birmingham
  • Birmingham Surgery Center, Birmingham
  • Brookwood Medical Center, Birmingham
  • Children’s Hospital, Birmingham
  • Ginsburg Dermatology Center, Birmingham
  • Montclair Dermatology, Birmingham
  • Premier Plastic Surgery Center-AL, Birmingham
  • Rousso Facial Plastic Surgery, Birmingham
  • St. Vincent’s Hospital, Birmingham
  • St. Vincent’s Hospital Outpatient Surgery, Birmingham
  • Trinity Medical Center, Birmingham
  • Veterans Medical Center-GALA, Birmingham
  • Cullman Regional Medical Center, Cullman
  • Parkway Medical Center, Decatur
  • Dothan Surgery Center, Dothan
  • Flowers Hospital, Dothan
  • Southeast Alabama Medical Center, Dothan
  • Southeast Eye Clinic, Dothan
  • Surgery Center South, Dothan
  • Medical Center Enterprise, Enterprise
  • Gulf Health Hospital, Fairhope
  • 
South Baldwin Regional Medical Center, Foley
  • 
Eliza Coffee Memorial Hospital, Florence
  • 
DeKalb Regional Medical Center, Fort Payne
Gadsden Regional Medical Center, Gadsden
Marion Regional Medical Center, Hamilton
  • Huntsville Hospital, Huntsville
  • Alabama Outpatient Surgery Center, Jasper
  • Alabama Orthopaedic Clinic, PC, Mobile
  • Mobile Infirmary, Mobile
  • Mobile Surgery Center, Mobile
  • 
Springhill Medical Center-Cardio, Mobile
  • 
Central Alabama Pain Management Center, Montgomery
  • Jackson Hospital and Clinic, Montgomery
  • 
The Surgery Center, Oxford
  • 
Bigelow Cosmetic Surgery Center, Scottsboro
  • Vaughan Regional Medical Center, Selma
  • Lanier Health Services, Valley
  • Brookwood Dermatology, Vestavia Hills

ADPH is advising patients who had a procedure at one of the above facilities anytime after May 21, 2012, to self-monitor for at least 3 months following the procedure for the signs and symptoms of any adverse events, meningitis or infection related to their procedure, as well as any redness or swelling at the injection site.

Source: WSFA